Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (271-280 of 362) with videos related to

Pageof 37
Sort By:
JAMA Network Open|May 26, 2026
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-AnalysisKristoffer Grundtvig Skaarup, Mats C H Lassen, Kaveh Hosseini, et al.
European Journal of Heart Failure|September 24, 2024
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE-MI echocardiographic substudyXiaowen Wang, Maria A Pabon, Maja Cikes, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Natural Language Processing for Adjudication of Heart Failure Hospitalizations in a Multi-Center Clinical TrialJonathan W Cunningham, Pulkit Singh, Christopher Reeder, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
Circulation|September 9, 2022
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic SubstudyAmil M Shah, Brian Claggett, Narayana Prasad, et al.
Circulation. Heart Failure|June 12, 2024
Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI TrialCarmine G De Pasquale, Brian Claggett, Karola Jering, et al.
European Heart Journal|May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsAkshay S Desai, John J V McMurray, Milton Packer, et al.
Journal of the American College of Cardiology|January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical TrialsPablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
European Heart Journal|July 2, 2014
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Michele Senni, Deepak K Gupta, et al.
Journal of Diabetes Research|January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease DurationJelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
Pageof 37

Showing results (271-280 of 362) with videos related to

Sort By:
Pageof 37
JAMA Network Open|May 26, 2026
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-AnalysisKristoffer Grundtvig Skaarup, Mats C H Lassen, Kaveh Hosseini, et al.
European Journal of Heart Failure|September 24, 2024
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE-MI echocardiographic substudyXiaowen Wang, Maria A Pabon, Maja Cikes, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Natural Language Processing for Adjudication of Heart Failure Hospitalizations in a Multi-Center Clinical TrialJonathan W Cunningham, Pulkit Singh, Christopher Reeder, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
Circulation|September 9, 2022
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic SubstudyAmil M Shah, Brian Claggett, Narayana Prasad, et al.
Circulation. Heart Failure|June 12, 2024
Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI TrialCarmine G De Pasquale, Brian Claggett, Karola Jering, et al.
European Heart Journal|May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsAkshay S Desai, John J V McMurray, Milton Packer, et al.
Journal of the American College of Cardiology|January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical TrialsPablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
European Heart Journal|July 2, 2014
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Michele Senni, Deepak K Gupta, et al.
Journal of Diabetes Research|January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease DurationJelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
Pageof 37